AzTrials
AzTrials

Psychiatric DisorderAUTON'HOMENCT07317388

Group Psychoeducation to Promote Independent Living in Individuals With Psychiatric Disorders

An observational study of Psychiatric Disorder, run by Centre hospitalier de Ville-Evrard, France at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study evaluates the effectiveness of group psychoeducation for users and carers to help people with severe psychiatric disorders achieve autonomy at home. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychiatric Disorder
How many people
24 participants
Where
1 siteFrance
Study dates
1 May 2025to Feb 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Participants with severe psychiatric disorders, managed by the RPS 93 platform, and volunteers for a home autonomy project.

Who may be able to join

  • Volunteer for a home autonomy project
  • Management of a mental health problem (mood disorder or psychotic disorder)
  • Consent for participation (non-opposition)
  • Taken care by the RPS 93 platform

Who cannot join

  • Acute clinical state

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Youcef BENCHERIF, Clinical Project Manager contact

01.43.09.32.32

y.bencherif@epsve.fr

France1 site, 1 recruiting
  • EPS VIlle Evrard - UNIRRE 93

    Neuilly-sur-Marne

    Raluca Rosetti, +33613616270, r.rosetti@epsve.fr

    Recruiting

Other trials in France

About this study

Official title: Study on the Effectiveness of Group Psychoeducation (for Users and Caregivers) in Promoting Autonomy at Home for Individuals With Psychatric Disorder.

This study evaluates the effectiveness of group psychoeducation for users and carers to help people with severe psychiatric disorders achieve autonomy at home.

Read the detailed description

The study will assess the autonomy of users with severe psychiatric disorders in a home setting before and after participation in the psychoeducation group. The program includes 10 sessions focusing on various aspects of daily living and cognitive functions.

Keywords
psychoeducation, autonomy, mental health, group therapy, independent living
Medical subject headings
Mental Disorders, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07317388
Study groupRoleWhat they receive
AUTON'HOME Group 1Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.
AUTON'HOME Group 2Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.
AUTON'HOME Group 3Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.
AUTON'HOME Group 4Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Life Habits Assessment Tool

    Assessing the autonomy of users with severe psychic pathologies in housing before and after participation in the psychoeducation group.

    Measured: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion

Secondary outcomes (7)
  1. Center for Epidemiologic Studies Depression Scale

    Assesses emotional impressions and depressive symptoms in caregivers.

    Measured: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion

  2. Zarit Burden Interview Scale

    Quantifies caregiver burden.

    Measured: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion

  3. Family Expectations Questionnaire

    It aims to collect the expectations of family members regarding the autonomy and daily functioning of their loved one living with a severe mental disorder.

    Measured: Baseline (prior to initiation of the AUTON'HOME psychoeducation program)

  4. Family Expectations Fulfillment Questionnaire

    It evaluates whether the expectations previously expressed by the family have been fulfilled, partially met, or unmet.

    Measured: At the end of the 10-week AUTON'HOME psychoeducation program and 3 months after program completion

  5. Positive and Negative Syndrome Scale

    Measures severity of psychiatric symptoms.

    Measured: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program

  6. Clinical Global Impression

    Assesses global improvement compared to baseline.

    Measured: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program

  7. Montreal Cognitive Assessment

    Screens for mild to moderate cognitive impairments.

    Measured: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2026
  2. Study start1 May 2025
  3. Primary completionFeb 2027 (estimated)
  4. Study completionFeb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07317388
Sponsor's protocol ID
0098_EPSVE_AUTON'HOME
Acronym
AUTON'HOME
Status last verified
Dec 2025
First submitted
26 Sep 2025
Last updated
5 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD002831. doi: 10.1002/14651858.CD002831.pub2.

    PubMed 21678337
  • Somerville, P., (1998). " Empowerment through Residence ", Housing Studies, Vol. 13, n° 2, pp. 233-258.

  • Richard, M.-J., Touroude, R., Loubier , D. (2018) Habitat et accompagnement. Santé mentale, 228, 42-47.

  • Pan AW, Fisher AG. The Assessment of Motor and Process Skills of persons with psychiatric disorders. Am J Occup Ther. 1994 Sep;48(9):775-80. doi: 10.5014/ajot.48.9.775.

    PubMed 7977620
  • Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste DV, Patterson TL. Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res. 2008 Mar;42(4):320-7. doi: 10.1016/j.jpsychires.2006.12.008. Epub 2007 Feb 15.

    PubMed 17303168
  • Leguay D, Cochet A, Matignon G, Hairy A, Fortassin O, Marion JM. [Social Autonomy Scale. First validation data]. Encephale. 1998 Mar-Apr;24(2):108-19. French.

    PubMed 9622789
  • Latalova K. Insight in bipolar disorder. Psychiatr Q. 2012 Sep;83(3):293-310. doi: 10.1007/s11126-011-9200-4.

    PubMed 22101737
  • Gaudelus, B., (2018). Quels outils pour évaluer la capacité à habiter, Santé mentale, 228,48-54.

  • Beaulieu A, Morin P, Provencher H, Dorvil H. [Work as a social determinant of health for mental health services consumers.]. Sante Ment Que. 2002;27(1):177-93. French.

    PubMed 18253624
  • Chambon, N., Picolet, É. & Sorba, M. (2020). L'intervention sociale à l'épreuve d'une préoccupation pour la santé mentale. Mobilisation du rétablissement et politique de logement d'abord. Revue française des affaires sociales, 97-116.

  • Barres, M., (2016) L'action de la psychiatrie pour l'accès et le maintien dans le logement des personnes vivant avec des troubles psychiques en Île-de-France. https://bibliotheques.ghu-paris.fr/doc_num.php?explnum_id=1299

  • Bond K, Anderson IM. Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials. Bipolar Disord. 2015 Jun;17(4):349-62. doi: 10.1111/bdi.12287. Epub 2015 Jan 16.

    PubMed 25594775
  • Baier M. Insight in schizophrenia: a review. Curr Psychiatry Rep. 2010 Aug;12(4):356-61. doi: 10.1007/s11920-010-0125-7.

    PubMed 20526897
  • Amado, C., Musset, T., & Gozlan, G., (2018). Le SAMSAH'Appart, espace d'évaluation et d'apprentissage. Santé mentale, 228, 69-70.

  • Alhadidi MM, Lim Abdullah K, Yoong TL, Al Hadid L, Danaee M. A systematic review of randomized controlled trials of psychoeducation interventions for patients diagnosed with schizophrenia. Int J Soc Psychiatry. 2020 Sep;66(6):542-552. doi: 10.1177/0020764020919475. Epub 2020 Jun 7.

    PubMed 32507073

Questions about this trial

What is this clinical trial studying?

An observational study of Psychiatric Disorder, run by Centre hospitalier de Ville-Evrard, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Youcef BENCHERIF, Clinical Project Manager (01.43.09.32.32, y.bencherif@epsve.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Life Habits Assessment Tool (time frame: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07317388, which also lists 15 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in